乳房切除术后放疗背景下背阔肌皮瓣联合假体即刻乳房再造:376例乳房再造分析
单术者标准化两阶段方案(背阔肌皮瓣+组织扩张器即刻再造,二期更换假体)回顾性分析201例患者共376例乳房再造,比较放疗与非放疗组结局;再造失败率非放疗组3.6%、放疗组16.6%(P=0.03),但放疗组失败中三分之一与放疗无关,校正后总体再造成功率无统计学差异。
要点
- 背阔肌皮瓣联合假体两阶段即刻再造在放疗背景下仍可安全应用。
- 放疗组再造失败率16.6%高于非放疗组3.6%(P=0.03)。
- 放疗组失败中三分之一与放疗无关,校正后成功率无显著差异。
核心结论
- 背阔肌皮瓣联合假体即刻再造是可靠安全的选择,即使接受辅助放疗,自体组织可减轻放疗后遗症。
研究设计与样本
- 单术者标准化重建方案的回顾性 chart review,纳入201例患者共376例乳房再造,按放疗状态比较人口学与结局。
- 两阶段方案:背阔肌皮瓣+组织扩张器即刻再造,二期更换假体。
主要发现
- 两组人口学特征相当。
- 除再造失败外,非放疗组与放疗组并发症及结局无差异。
- 再造失败率非放疗组3.6%、放疗组16.6%(P=0.03)。
- 放疗组失败中三分之一与放疗无关,校正后总体再造成功率两组无统计学差异。
关键数值与推荐
- 再造成功定义为无需在兩阶段方案之外进一步行自体组织再造。
- 再造失败率:非放疗组3.6%,放疗组16.6%(P=0.03)。
临床怎么用
- 可将背阔肌皮瓣联合假体两阶段即刻再造作为乳房切除术后需辅助放疗患者的可选方案。
- 放疗患者需关注再造失败风险,但部分失败原因与放疗无关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In immediate breast reconstruction, the plastic surgeon must strive to create an aesthetically pleasing result while minimizing complications. The latissimus dorsi (LD) myocutaneous flap has long been used a workhorse flap in breast reconstruction. Often times, it is used a salvage flap after other methods of breast reconstruction have failed. In this study, we review the use of this flap in conjunction with prosthetic devices, regardless of the need for adjuvant radiation, to determine the safety and efficacy of this approach as a primary method of reconstruction. METHODS: A single surgeon practice with a standardized reconstructive algorithm was reviewed. This compromises a 2-stage approach involving the use of LD myocutaneous flaps and tissue expanders for immediate reconstruction after mastectomy, followed by exchange for implants at a secondary surgery. A retrospective chart review was performed on 201 patients (376 breast reconstructions) who met inclusion criteria. Patient demographics and outcomes were compared based on radiation status. The primary outcome, reconstructive success, was defined as no need for further autologous reconstruction beyond the 2-stage approach utilized. RESULTS: Statistical analysis was performed on both patient demographics, complications, and reconstructive outcomes. Demographics were equivalent between the 2 groups. When analyzing complications and outcomes, there was no difference between nonradiated patients and radiated patients except when looking at reconstructive loss, which was 3.6% in the nonradiated group and 16.6% in the radiated group (P = 0.03). However, one third of the patients in the radiated group who had reconstructive losses were due to reasons not related to radiation therapy. Taking this into account, overall reconstructive success showed no statistical significance between the 2 groups. CONCLUSIONS: The findings from this study show that immediate reconstruction with LD myocutaneous flaps in conjunction with prosthetic devices is a reliable and safe option, even in the setting of adjuvant radiation therapy, as the autologous tissue mitigates many sequelae of radiation therapy. Not only does this type of reconstruction provide an aesthetically pleasing result in 2 stages, but also has a favorable complication profile and success rate.
引用
- Chiasson KF, Kumbla PA, Restrepo RD, et al. Immediate Latissimus Dorsi and Prosthetic Reconstruction in the Setting of Postmastectomy Radiation: An Analysis of 376 Breast Reconstructions. Ann Plast Surg. 2020. PMID: 32039998. doi:10.1097/SAP.0000000000002279
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。